This company listing is no longer active
Salud financiera de hoja de balance de Metacrine
Salud financiera controles de criterios 6/6
Metacrine has a total shareholder equity of $37.1M and total debt of $13.8M, which brings its debt-to-equity ratio to 37.2%. Its total assets and total liabilities are $55.0M and $18.0M respectively.
Información clave
37.2%
Ratio deuda-patrimonio
US$13.79m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$52.75m |
| Patrimonio | US$37.07m |
| Total pasivo | US$17.97m |
| Activos totales | US$55.04m |
Actualizaciones recientes sobre salud financiera
Recent updates
Equillium acquires Metacrine to extend cash runway through 2024
Sep 06Metacrine initiated buy at H.C. Wainwright citing novelty in therapeutic platform
Jun 14Metacrine completes enrollment in mid-stage NASH trial
Jun 02Metacrine initiates mid-stage study of MET409 + empagliflozin in diabetes and NASH
Jan 05What Percentage Of Metacrine, Inc. (NASDAQ:MTCR) Shares Do Insiders Own?
Dec 16
Metacrine reports Q3 results
Nov 12Análisis de la situación financiera
Pasivos a corto plazo: MTCR's short term assets ($55.0M) exceed its short term liabilities ($4.5M).
Pasivo a largo plazo: MTCR's short term assets ($55.0M) exceed its long term liabilities ($13.4M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: MTCR has more cash than its total debt.
Reducción de la deuda: MTCR had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: MTCR has sufficient cash runway for more than a year based on its current free cash flow.
Pronóstico de cash runway: MTCR has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 21.8% each year.